Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 193Carcinoma, Non-Small-Cell Lung 160Ovarian Neoplasms 96Lung Neoplasms 58Fallopian Tube Neoplasms 57Neoplasms 50Triple Negative Breast Neoplasms 36Neoplasm Metastasis 36Esophageal Neoplasms 22Carcinoma, Ovarian Epithelial 22Parkinson Disease 4, Autosomal Dominant Lewy Body 21Stomach Neoplasms 20Squamous Cell Carcinoma of Head and Neck 20Head and Neck Neoplasms 19Endometrial Neoplasms 19Adenocarcinoma of Lung 17Melanoma 15Breast Neoplasms, Male 15Urinary Bladder Neoplasms 13Carcinoma 12Uterine Cervical Neoplasms 11Recurrence 11Carcinoma, Squamous Cell 11Brenner Tumor 11Adenocarcinoma Of Esophagus 10Small Cell Lung Carcinoma 9Peritoneal Neoplasms 9Esophageal Squamous Cell Carcinoma 9Adenocarcinoma, Bronchiolo-Alveolar 9Prostatic Neoplasms 8

Interventions

Gemcitabine 6Irinotecan 4130-nm albumin-bound paclitaxel 4Cisplatin 3Albumin-Bound Paclitaxel 3napabucasin 2Leucovorin 2Imatinib Mesylate 2Everolimus 2Ascorbic Acid 2spartalizumab 1pralsetinib 1pembrolizumab 1dostarlimab 1copanlisib 1alectinib 1Ramucirumab 1Paclitaxel 1NUC-1031 1Levoleucovorin 1KRN-330 1HhAntag691 1Fluorouracil 1Cyclophosphamide 1Capecitabine 1Bevacizumab 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Digestive System Neoplasms × Paclitaxel × Clear all
NCT03077685 2024-06-24

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

NanOlogy, LLC

Phase 2 Completed
54 enrolled 17 charts
Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡